| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 09/18/2003 | US20030176715 Method for the vapour-phase partial oxidation of aromatic hydrocarbons |
| 09/18/2003 | US20030176496 Administering an antiproliferative agent in combination with a potentiating effective amount of a N- substituted dithiocarbamate ester or a pharmaceutically acceptable salt thereof |
| 09/18/2003 | US20030176485 Calcium receptor active compounds |
| 09/18/2003 | US20030176441 Inhibitsthe binding of eotaxin to the CCR-3 receptor and thereby provide a means of combating eosinophil induced diseases, such as asthma |
| 09/18/2003 | US20030176439 For therapy and prophylaxis of thromboembolic diseases and restenoses; reversible inhibitors of the blood clotting enzyme factor VIIa |
| 09/18/2003 | US20030176366 Topical application of ascorbic acid compounds for augmenting the synthesis of epidermal ceramides |
| 09/18/2003 | US20030176361 Having cytoprotective activity and protective activity for neuroinflammation, and neurodegenerative disorders; for use in therapy of stroke, cerebral ischemia, myocardial infarction, myocardial ischemia, chronic heart failure, inflammation |
| 09/18/2003 | US20030175943 Biosynthesis of antitumor agents |
| 09/18/2003 | US20030175267 Method for the treatment of inflammatory joint disease |
| 09/18/2003 | US20030172471 1,3-diamino-4-(aminomethyl) - benzene derivatives and colorants containing the said compounds |
| 09/18/2003 | CA2482191A1 Spiro compounds with npy antagonistic activity |
| 09/18/2003 | CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 09/18/2003 | CA2478948A1 5-}2-hydroxy-3-`1-(3-trifluoromethylphenyl)-cyclopropyl!-propionylamino}-phtalide and related compounds with progesterone receptor modulating a ctivity for use in fertility control and hormone replacement therapy |
| 09/18/2003 | CA2478921A1 Novel chalcone derivatives and uses thereof |
| 09/18/2003 | CA2459834A1 Citalopram for the treatment of elevated blood pressure |
| 09/17/2003 | EP1344776A1 5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders |
| 09/17/2003 | EP1343777A1 Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate |
| 09/17/2003 | EP1343775A2 Piperazine derivatives |
| 09/17/2003 | EP1343768A1 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
| 09/17/2003 | EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/17/2003 | EP1343744A2 Method for producing alcohols by hydrogenating carbonyl compounds |
| 09/17/2003 | EP1343743A2 Method for the production of tetrahydrofuran |
| 09/17/2003 | EP1343561A1 Serine protease inhibitors |
| 09/17/2003 | EP1249449B1 Method for obtaining 2-bromo-5-(2-bromo-2-nitrovinyl)-furan |
| 09/17/2003 | EP1165536B1 Process for the preparation of alpha-methylene lactones |
| 09/17/2003 | EP0668762B1 Isobutenyl-substituted taxanes and their pharmaceutical compositions |
| 09/17/2003 | CN1443180A Novel compounds having antiinflamatory activity process for their preparation and pharmaceutical compositions containing them |
| 09/17/2003 | CN1443179A Aniline derivatives |
| 09/17/2003 | CN1443155A Compounds to treat alzheimer's disease |
| 09/17/2003 | CN1443154A 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 09/17/2003 | CN1442426A Diterpene compound of veronicastrum sibiricum and its extraction separation method |
| 09/17/2003 | CN1121401C Aminophenol derivates |
| 09/17/2003 | CN1121379C Synthesis and use of retinene derivative having negative hormone and/or antagonist activities |
| 09/17/2003 | CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors |
| 09/16/2003 | US6620949 Process for the simultaneous production of maleic anhydride and its hydrogenated derivatives |
| 09/16/2003 | US6620947 Such as ((2R(1E,3R),3S(4Z),4R))-7-(Tetrahydro-2-(4-(3-chlorophenoxy)-3-hydroxy-1 -butenyl)-4-hydroxy-3-furanyl)-4-heptenoic acid |
| 09/16/2003 | US6620933 Dyes having acid reistance and stability used as colors for silver halide photographic, photosensitive materials, ink jet or thermal printing and as toners in electrophotography, electroluminescence or television displays |
| 09/16/2003 | US6620835 Method of inhibiting matrix metalloproteinases |
| 09/16/2003 | CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 09/16/2003 | CA2068089C Method and compositions for using non-ionic contrast agents to reduce the risk of clot formulation in diagnostic procedures |
| 09/16/2003 | CA2037575C N-(4-piperidinyl) (dihydrobenzofuran or dihydro-2h-benzopyran) carboxamide derivatives |
| 09/12/2003 | WO2003074536A1 Novel organosilicon compound, optically active isomers thereof, process for producing the organosilicon compound, and use thereof |
| 09/12/2003 | WO2003074507A1 Method for purifying tetrahydrofuran by distillation |
| 09/12/2003 | WO2003074491A1 O-cyclopropyl-carboxanilides and their use as fungicides |
| 09/12/2003 | WO2003074475A2 Substituted aryl ketones |
| 09/12/2003 | WO2003074038A1 Methods for treating diseases related to intraocular pressure |
| 09/12/2003 | WO2003073987A2 Compounds that modulate the activity of ptp-1b and tc-ptp |
| 09/12/2003 | CA2477392A1 Methods for treating diseases related to intraocular pressure |
| 09/12/2003 | CA2477119A1 Compounds that modulate the activity of ptp-1b and tc-ptp |
| 09/11/2003 | WO2003074482A1 Method for the simultaneous production of tetrahydrofurans and pyrrolidones |
| 09/11/2003 | WO2003074046A1 Antidepressant |
| 09/11/2003 | US20030171601 Optionally substituted cyclohexanone is reacted with an alkyl dioxy- or dihydroxyacetate for form an alkyl 2-(2-oxocyclo-hexyl)-2-hydroxyacetate; catalytic gas phase dehydrogenation |
| 09/11/2003 | US20030171428 Anticancer agents; anticholesterol agents; cognition activators; rheumatic diseases |
| 09/11/2003 | US20030171427 Drechsleranol derivatives, processes for their preparation and their use |
| 09/11/2003 | US20030171423 Enzyme inhibitor for treating HIV infections in mammals; viricides; patient is suffering from a multi-drug resistant HIV infection; AIDS therapy |
| 09/11/2003 | US20030171422 Aldose reductase inhibitors; antidiabetic agents |
| 09/11/2003 | US20030171371 For treatment of psoriasis |
| 09/11/2003 | US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
| 09/11/2003 | US20030171341 Method for modulating the activity of a Rho C enzyme, comprising: contacting said Rho C enzyme with an effective amount of a compound of formula 1: |
| 09/11/2003 | US20030171219 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 09/11/2003 | US20030171213 Catalyst system and a process for the preparation of a nonracemic chiral alcohol by hydrogenation of a ketone using the catalyst system, wherein the catalyst system comprises ruthenium, a nonracemic chiral diphosphine ligand, an |
| 09/11/2003 | US20030170381 Piezoelectric element and process for production thereof |
| 09/10/2003 | EP1341786A1 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain |
| 09/10/2003 | EP1341779A2 Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 09/10/2003 | EP1341754A1 Substituted anthranilic acids |
| 09/10/2003 | EP1341610A1 Porous catalyst for the hydrogenation of maleic anhydride to tetrahydrofuran |
| 09/10/2003 | EP1341476A2 Intrasvascular drug delivery device and use therefor |
| 09/10/2003 | EP1149084B1 Method for producing l-ascorbic acid |
| 09/10/2003 | EP1137644B1 Benzofuran derivatives, their preparation and use |
| 09/10/2003 | EP1091948B9 Tubulin binding compounds (cobra) |
| 09/10/2003 | EP0991619B1 Inhibitors of alpha 4-beta 1 mediated cell adhesion |
| 09/10/2003 | EP0942938B1 Supported catalyst system, method for the production and use thereof in olefin polymerization |
| 09/10/2003 | CN1441800A Beta 3 adrenergic agonists |
| 09/10/2003 | CN1441795A Method for preparation of citalopram |
| 09/10/2003 | CN1441794A Lipid-rich plague inhibitors |
| 09/10/2003 | CN1441793A Tocotrienolquinone cyclisation product with anti-hypercholesterol effect |
| 09/10/2003 | CN1441775A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 09/10/2003 | CN1440968A Prepn process of citalopram hydrobromide |
| 09/10/2003 | CN1120844C Lactone compound and its synthesis and use |
| 09/10/2003 | CN1120838C Dihydrobenzofuran compounds useful as anti-inflammatong agents |
| 09/10/2003 | CN1120837C Low-viscosity liquid alicyclic exoxy compound and its preparing process |
| 09/09/2003 | US6617464 Heating levulinic acid in the presence of hydrogen and a metal catalyst having hydrogenation and ring-closing function |
| 09/09/2003 | US6617463 Method for the production of L-ascorbic acid by lactonization of 2-keto-L-gulonic acid or s2-keto-L-gulonate esters |
| 09/09/2003 | US6617352 Compounds and methods for the inhibition of the expression of VCAM-1 |
| 09/09/2003 | US6617350 Inhibitors of aspartyl protease |
| 09/09/2003 | US6617343 Treating non-insulin-dependent diabetes mellitus |
| 09/09/2003 | US6617317 Boronic ester and acid compositions |
| 09/09/2003 | CA2360287C Crystalline base of citalopram |
| 09/09/2003 | CA2248953C Novel benzofuranone derivatives and process for producing the same |
| 09/09/2003 | CA2037114C N-cycloalkylalkylamines, their process of preparation, their use as medication and their synthetic intermediates |
| 09/09/2003 | CA2031480C Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity |
| 09/04/2003 | WO2003072566A1 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
| 09/04/2003 | WO2003072565A1 Process for the production of citalopram |
| 09/04/2003 | WO2003072564A1 Purification of citalopram |
| 09/04/2003 | WO2003072563A1 Amorphous citalopram salts |
| 09/04/2003 | WO2003072562A1 Amorphous citalopram |
| 09/04/2003 | WO2003072561A1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 09/04/2003 | WO2003072553A1 N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials |
| 09/04/2003 | WO2003072535A2 Substituted hydroxyethylamines |
| 09/04/2003 | WO2003072528A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |